Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A condition marked by progressive cerebellar ataxia combined with myoclonus usually presenting in the third decade of life or later. Additional clinical features may include generalized and focal seizures, spasticity, and dyskinesias. Autosomal recessive and autosomal dominant patterns of inheritance have been reported. Pathologically, the dentate nucleus and brachium conjunctivum of the cerebellum are atrophic, with variable involvement of the spinal cord, cerebellar cortex, and basal ganglia. (From Joynt, Clinical Neurology, 1991, Ch37, pp60-1)
Features include: Ataxia, Atrophy of the dentate nucleus, and Sudden, brief involuntary muscle jerks (myoclonus).
Organ System | Phenotype Count | Example Features |
|---|---|---|
Brain and nerves | 2 | Ataxia, Sudden, brief involuntary muscle jerks (myoclonus) |
Muscles |
Biomarker and diagnostic research for myoclonic cerebellar dyssynergia has been reported in the published literature.
1 clinical trial registered. Interventions under study include medical devices. Pipeline includes 1 NA. Research is primarily industry-sponsored.
114 publications have been identified in PubMed for myoclonic cerebellar dyssynergia. Kisho has analyzed 53 by research type. Research spans Review / Meta-Analysis (32%), Epidemiology / Natural History (25%), and Basic Science / Preclinical (13%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 17 |
Data assembled from 5 of 12 sources · Last updated Sep 20, 2026, 10:53 AM UTC
Patient Advocacy Groups (PAGs) provide support, resources, and community for patients and caregivers.
Online Mendelian Inheritance in Man
1 |
Atrophy of the dentate nucleus |
Disease patterns and progression | 13 | 25% |
Laboratory research | 7 | 13% |
Patient case studies | 6 | 11% |
Testing and diagnosis research | 5 | 9% |
Clinical study results | 2 | 4% |
New treatment approaches | 2 | 4% |
Other research | 1 | 2% |
Torrico TJ (2026). [PMID: 32644660](https://pubmed.ncbi.nlm.nih.gov/32644660/). *Unknown Journal*. [Gene Therapy / Novel Therapeutics]
Hahn W (2026). [PMID: 41716779](https://pubmed.ncbi.nlm.nih.gov/41716779/). *Mol Genet Metab Rep*. [Case Report / Case Series]
Galissi L (2026). [PMID: 40485245](https://pubmed.ncbi.nlm.nih.gov/40485245/). *J Eur Acad Dermatol Venereol*. [Epidemiology / Natural History]
Torrico TJ (2026). [PMID: 32644751](https://pubmed.ncbi.nlm.nih.gov/32644751/). *Unknown Journal*. [Epidemiology / Natural History]
Daley SF (2026). [PMID: 32310484](https://pubmed.ncbi.nlm.nih.gov/32310484/). *Unknown Journal*. [Diagnostic / Biomarker]
David C (2026). [PMID: 41395910](https://pubmed.ncbi.nlm.nih.gov/41395910/). *Ann Rheum Dis*. [Epidemiology / Natural History]
Al Saif F (2026). [PMID: 31095356](https://pubmed.ncbi.nlm.nih.gov/31095356/). *Unknown Journal*. [Epidemiology / Natural History]
Shah KP (2026). [PMID: 34033319](https://pubmed.ncbi.nlm.nih.gov/34033319/). *Unknown Journal*. [Diagnostic / Biomarker]
Sonagra AD (2026). [PMID: 37603641](https://pubmed.ncbi.nlm.nih.gov/37603641/). *Unknown Journal*. [Epidemiology / Natural History]
Gileles-Hillel A (2025). [PMID: 40344691](https://pubmed.ncbi.nlm.nih.gov/40344691/). *Sleep Med*. [Diagnostic / Biomarker]